Governor Spencer Cox joins Kelvyn Cullimore of BioUtah in recognizing Co-Diagnostics, Inc. (Nasdaq: CODX), a Utah diagnostics company with a patented platform for developing advanced molecular diagnostic tests, following its recent announcement of the formation of CoMira Diagnostics, a joint venture (JV) in the Kingdom of Saudi Arabia.

"Co-Diagnostics is a Utah-born company competing on the world stage," said Governor Spencer Cox. "Their expansion across the Middle East and North Africa reflects the strength of Utah's life sciences and the grit of our entrepreneurs. We're proud to see a Utah company building tools that help more patients around the world."

Kelvyn Cullimore, President and CEO of BioUtah, added "BioUtah is proud to count Co-Diagnostics among its Elite members.  Their recent signing of a definitive JV agreement with a company in the Kingdom of Saudi Arabia (KSA) further confirms Co-Diagnostics' expanding leadership and presence on the worldwide stage.  We couldn't be more pleased with the way they represent the Utah life sciences community, one of the fastest growing in the United States."